Nattokinase Attenuates Acute Cerebral Infarction in a Rat Model of Middle Cerebral Artery Occlusion
In Vivo · 2026
DOI: 10.21873/invivo.14243 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2026. Verfasst von Takashi Tanikawa und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Saitama, Japan; tanikawa@josai.ac.jp. Hauptthemen laut MEDLINE: Infarction, Middle Cerebral Artery, Subtilisins, Neuroprotective Agents, Cerebral Infarction. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Saitama, Japan; tanikawa@josai.ac.jp.
- Contek Life Science Co., Ltd., Taipei, Taiwan, R.O.C.
- CellMark Japan, Tokyo, Japan.
- CellMark Japan, Tokyo, Japan kitamura@josai.ac.jp.
Zitieren
APA
Tanikawa, T., Yu, J., Hsu, K., Chen, S., Ishii, A., & Kitamura, M. (2026). Nattokinase Attenuates Acute Cerebral Infarction in a Rat Model of Middle Cerebral Artery Occlusion. In Vivo. https://doi.org/10.21873/invivo.14243
Vancouver
Tanikawa T, Yu J, Hsu K, Chen S, Ishii A, Kitamura M. Nattokinase Attenuates Acute Cerebral Infarction in a Rat Model of Middle Cerebral Artery Occlusion. In Vivo. 2026. doi:10.21873/invivo.14243
BibTeX
@article{Tanikawa2026,
author = {Tanikawa, Takashi and Yu, James and Hsu, Kate and Chen, Shinder and Ishii, Ayako and Kitamura, Masashi},
title = {Nattokinase Attenuates Acute Cerebral Infarction in a Rat Model of Middle Cerebral Artery Occlusion},
journal = {In Vivo},
year = {2026},
doi = {10.21873/invivo.14243}
}
EUVIMED